Literature DB >> 16500196

Pulmonary rehabilitation in patients undergoing lung-volume reduction surgery.

Matthew N Bartels1, Heakyung Kim, Jonathan H Whiteson, Augusta S Alba.   

Abstract

UNLABELLED: Chronic obstructive pulmonary disease (COPD) is the most common form of primary pulmonary disability. Few effective treatment options exist for it, but recently, lung-volume reduction surgery (LVRS) has been shown to be effective in selected patients with emphysema. Pulmonary rehabilitation is an integral part of the preparation for and recovery from the procedure and has significant benefit in helping to improve the quality of life and conditioning of patients with COPD who undergo LVRS. OVERALL ARTICLE
OBJECTIVES: (a) To describe the role of pulmonary rehabilitation in LVRS, (b) to understand the components of a comprehensive pulmonary rehabilitation program, and (c) to describe the effects of a pulmonary rehabilitation program.

Entities:  

Mesh:

Year:  2006        PMID: 16500196     DOI: 10.1016/j.apmr.2005.12.013

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  3 in total

1.  A comprehensive protocol for physiokinesis therapy and enhanced recovery after surgery in patients undergoing video-assisted thoracoscopic surgery lobectomy.

Authors:  Alessandro Bertani; Paolo Ferrari; Danilo Terzo; Emanuele Russo; Gaetano Burgio; Lavinia De Monte; Francesco Raffaele; Andrea Droghetti; Roberto Crisci
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

2.  Intensive rehabilitation as an independent determinant of better outcome in patients with lung tumors treated by thoracic surgery.

Authors:  Oliwia Glogowska; Maciej Glogowski; Sebastian Szmit
Journal:  Arch Med Sci       Date:  2016-06-20       Impact factor: 3.318

3.  The Expressions of Hope in the Face of Complex Surgery: Experiences of Patients and Their Loved Ones.

Authors:  Karen M Baur; Jill Chamberlain; M Cecilia Wendler; Paula Harwood; Joni Colle; Deb Yeaman
Journal:  J Patient Exp       Date:  2018-10-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.